Krakauer, Marcio
Botero, Jose Fernando
Lavalle-González, Fernando J.
Proietti, Adrian
Barbieri, Douglas Eugenio
Funding for this research was provided by:
Abbott
Article History
Received: 28 October 2020
Accepted: 18 March 2021
First Online: 9 April 2021
Declarations
:
: Not applicable.
: Authors agree to publish the article in Diabetology & Metabolic Syndrome.
: Marcio Krakauer has received grants from and participated in Advisory Boards for Abbott, AstraZeneca, Biomm, Boehringer, Lilly, Medtronic, Merck, MSD, Novo Nordisk, P&G Health, Roche, and Sanofi. Jose Fernando Botero has received grants from and participated in Advisory Boards for Abbott, Novo Nordisk, and Sanofi. Fernando J Lavalle-González has received grants from and participated in Advisory Boards for Abbott, Sanofi, Novo Nordisk, Eli Lilly, Boehringer, MSD, Silanes, Janssen, AstraZeneca, Merck. Adrian Proietti has received conferences fees and participated in Advisory Boards for Abbott and Medtronic. Douglas Eugenio Barbieri is a Regional Medical Director of Abbott Diabetes Care.